Nov 22, 2016 13:45 pm UTC| Business
PORTLAND, Ore., Nov. 22, 2016 -- Kaya Holdings, Inc. (KAYS) announced today that it has filed its third quarterly report for 2016, in which the Company details its financial results from operations, the licensing and...
Nov 22, 2016 13:44 pm UTC| Business
DALLAS, Nov. 22, 2016 -- Bayport International Holdings, Inc. (OTCP:BAYP) is pleased to announce an exciting change in direction for the company. Bayport is currently evaluating multiple business options in the cannabis...
Open MRI of Connecticut Goes Live on eRAD Workflow Solutions
Nov 22, 2016 13:30 pm UTC| Business
GREENVILLE, S.C., Nov. 22, 2016 -- eRAD announced today that it has successfully deployed its imaging workflow solutions, including RIS, PACS and Speech Recognition, at Open MRI of Connecticut. eRAD will shortly...
Aqua Metals to Attend Investor Conferences in December
Nov 22, 2016 13:30 pm UTC| Business
ALAMEDA, Calif., Nov. 22, 2016 -- Aqua Metals (AQMS), which is commercializing a non-polluting electrochemical lead recycling technology called AquaRefining™, today announced that management will attend the Benchmark...
Acacia Communications Named Silver Winner at MassEcon “Impact” Awards
Nov 22, 2016 13:30 pm UTC| Business
MAYNARD, Mass., Nov. 22, 2016 -- Acacia Communications, Inc. (NASDAQ:ACIA), a leading provider of high-speed coherent optical interconnect products, today announced that it has been named a silver winner of MassEcon’s...
Vericel to Present at 28th Annual Piper Jaffray Healthcare Conference
Nov 22, 2016 13:30 pm UTC| Business
CAMBRIDGE, Mass., Nov. 22, 2016 -- Vericel Corporation (Nasdaq:VCEL), a leading developer of autologous expanded cell therapies for the treatment of patients with serious diseases and conditions, today announced that...
OncoMed Pharmaceuticals to Present at the 28th Annual Piper Jaffray Healthcare Conference
Nov 22, 2016 13:30 pm UTC| Business
REDWOOD CITY, Calif., Nov. 22, 2016 -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a biopharmaceutical company focused on discovering and developing novel anti-cancer stem cell and immuno-oncology therapeutics,...